Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 5,232 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Infection Clear all

Conditions: HIV Infections
Interventions: Kaletra + Current Dual NRTI Backbone, Current Regimen; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Wound Closure, Brain Tumor Adult, Spine, Neurovascular, Hemorrhagic Stroke, Intracerebral, Traumatic Brain Injury
Interventions: STRATAFIX PDS and Monocryl suture; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lansing, Michigan

Conditions: Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)
Interventions: vitamin D3, omega-3 fatty acids (fish oil), Vitamin D3 placebo, fish oil placebo; Dietary Supplement · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 25,874 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sepsis, Shock, Septic, Sepsis Syndrome, Septicemia, Infection
Interventions: E5564; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 17
States / cities: Mobile, Alabama • San Diego, California • Santa Barbara, California + 14 more

Conditions: Sepsis
Interventions: Pediatric sepsis screening tool (either algorithmic or manual); Diagnostic Test
Lead sponsor: Computer Technology Associates, Inc.; Industry
Eligibility: 3 Months to 45 Years
Enrollment: 12,961 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Meningococcal Infections, Meningitis
Interventions: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: East Stroudsburg, Pennsylvania

Conditions: Urinary Tract Infections, Pyelonephritis Acute, Intraabdominal Infections
Interventions: Sulopenem; Drug
Lead sponsor: Iterum Therapeutics, International Limited; Industry
Eligibility: 12 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Thermal Burn
Interventions: thin Integra® (125 cm2); Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 125 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Infections, Urinary Tract
Interventions: GSK2251052, imipenem-cilastatin, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: Los Angeles, California • Council Bluffs, Iowa • Topeka, Kansas + 1 more

Conditions: Tinea Pedis
Interventions: NAFT-600 ( naftin 2 % gel ), Placebo; Drug
Lead sponsor: Merz North America, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 855 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 22
States / cities: Phoenix, Arizona • San Diego, California • San Francisco, California + 19 more

Conditions: HIV Infections
Interventions: Quadrivalent HPV Vaccine, Placebo Vaccine for Male Participants Only, Placebo Vaccine for Female Participants Only; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 27 Years and older
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 22
States / cities: Los Angeles, California • Palo Alto, California • San Diego, California + 14 more

Conditions: Respiratory Syncytial Virus Infections
Interventions: Not listed
Lead sponsor: MedImmune LLC; Industry
Eligibility: 1 Month to 6 Months
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 59
States / cities: Birmingham, Alabama • Benton, Arkansas • Jonesboro, Arkansas + 50 more

Conditions: COVID
Interventions: Convalescent Plasma, Standard Donor Plasma; Biological
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Otomycosis
Interventions: miconazole 2% oil, vehicle oil; Drug
Lead sponsor: Hill Dermaceuticals, Inc.; Industry
Eligibility: 7 Years and older
Enrollment: 382 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 12
States / cities: Chula Vista, California • La Jolla, California • Roseville, California + 9 more

Conditions: Catheter-related Infections
Interventions: Mino-Lok, Antibiotic lock; Drug
Lead sponsor: Leonard-Meron Biosciences, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 19
States / cities: Washington D.C., District of Columbia • Gainesville, Florida • Hines, Illinois + 16 more

Conditions: Complicated Skin and Skin Structure Infection
Interventions: intravenous iclaprim or intravenous linezolid; Drug
Lead sponsor: Arpida AG; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 5
States / cities: National City, California • Boise, Idaho • Indianapolis, Indiana + 2 more

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: HIV-1 Infection
Interventions: Teropavimab, Zinlirvimab, Lenacapavir Tablet, Lenacapavir Injection, Antiretroviral Therapy; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 29
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 25 more

Conditions: Attention Deficit Disorder With Hyperactivity, HIV Infections, Paralysis
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Wound, Bacterial Infections, Diabetes Mellitus, Infected Ulcer of Skin
Interventions: Finger prick test for HbA1c measurement, Punch Biopsy, Vac Sponge Collection, Ankle Brachial Index; Diagnostic Test · Procedure · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 5
States / cities: Indianapolis, Indiana • Columbus, Ohio

Conditions: Paralytic Lagophthalmos, Corneal Exposure
Interventions: temporary magnetic system for tarsorrhaphy (MST); Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Molluscum Contagiosum
Interventions: VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102; Combination Product
Lead sponsor: Verrica Pharmaceuticals Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 18
States / cities: Birmingham, Alabama • Dothan, Alabama • Little Rock, Arkansas + 15 more

Conditions: COVID-19
Interventions: Positive COVID Test Result - Hypothetical Scenario, Negative COVID Test Result - Hypothetical Scenario, Unavailable COVID Test Result - Hypothetical Scenario; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 110 Years
Enrollment: 1,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Meningitis, Cryptococcal, HIV Infections
Interventions: Fluconazole, Amphotericin B; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 38
States / cities: Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 28 more

Search by objective public record fields.

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool

Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®

Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents

Single-Stage Integra Reconstruction in Burns

GSK2251052 in Complicated Urinary Tract Infection

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Convalescent Plasma vs. Standard Plasma for COVID-19

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

Cigarette Smoke and Susceptibility to Influenza Infection

A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Assessment of Attentional Functioning in Children With HIV-1 Infection

Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing

Self-Adhering Magnetic Device to Treat Corneal Exposure

Cantharidin Application in Molluscum Patients-1

Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome